Fig. 4From: Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertensionChange in monthly headache days (MHC) in patients treated with GLP-1-RAs and controls (a). Fifty percent responder rate at M6 was 75.0% and 33.3% in the GLP-1-RA and the UCWM group, respectively (b). *p < 0.05, **p < 0.01Back to article page